Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Pluda

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|June 17, 2000
High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasmaM A Rudek, C L March, K S Bauer, et al.
Antiviral Research|October 1, 1995
Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (--)-2',3'-dideoxy-3'-thiacytidineM F Kavlick, T Shirasaka, E Kojima, et al.
AIDS (London, England)|January 1, 1997
Effect of combination therapy with zidovudine and didanosine on neuropsychological functioning in patients with symptomatic HIV disease: a comparison of simultaneous and alternating regimensP Brouwers, M Hendricks, J A Lietzau, et al.
AIDS Research and Human Retroviruses|November 1, 1990
Quantitative analysis of HIV-1 proviral DNA in peripheral blood mononuclear cells from patients with AIDS or ARC: decrease of proviral DNA content following treatment with 2',3'-dideoxyinosine (ddI)S Aoki, R Yarchoan, R V Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Clinical trial designs for cytostatic agents: are new approaches needed?E L Korn, S G Arbuck, J M Pluda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
New drugs in non-Hodgkin's lymphomaS G Arbuck, J M Sorensen, M C Christian, et al.
American Journal of Hematology|April 3, 2001
Reversible sideroblastic anemia associated with the tetracycline analogue COL-3M A Rudek, M Horne, W D Figg, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Initial clinical experience with dideoxynucleosides as single agents and in combination therapyR Yarchoan, J M Pluda, C F Perno, et al.
Pharmacotherapy|January 1, 1997
The pharmacokinetics of TNP-470, a new angiogenesis inhibitorW D Figg, J M Pluda, R M Lush, et al.
Seminars in Oncology|April 1, 1997
Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer InstituteM C Christian, J M Pluda, P T Ho, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Pharmaceutical and Biomedical Analysis|June 17, 2000
High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasmaM A Rudek, C L March, K S Bauer, et al.
Antiviral Research|October 1, 1995
Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (--)-2',3'-dideoxy-3'-thiacytidineM F Kavlick, T Shirasaka, E Kojima, et al.
AIDS (London, England)|January 1, 1997
Effect of combination therapy with zidovudine and didanosine on neuropsychological functioning in patients with symptomatic HIV disease: a comparison of simultaneous and alternating regimensP Brouwers, M Hendricks, J A Lietzau, et al.
AIDS Research and Human Retroviruses|November 1, 1990
Quantitative analysis of HIV-1 proviral DNA in peripheral blood mononuclear cells from patients with AIDS or ARC: decrease of proviral DNA content following treatment with 2',3'-dideoxyinosine (ddI)S Aoki, R Yarchoan, R V Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Clinical trial designs for cytostatic agents: are new approaches needed?E L Korn, S G Arbuck, J M Pluda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
New drugs in non-Hodgkin's lymphomaS G Arbuck, J M Sorensen, M C Christian, et al.
American Journal of Hematology|April 3, 2001
Reversible sideroblastic anemia associated with the tetracycline analogue COL-3M A Rudek, M Horne, W D Figg, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Initial clinical experience with dideoxynucleosides as single agents and in combination therapyR Yarchoan, J M Pluda, C F Perno, et al.
Pharmacotherapy|January 1, 1997
The pharmacokinetics of TNP-470, a new angiogenesis inhibitorW D Figg, J M Pluda, R M Lush, et al.
Seminars in Oncology|April 1, 1997
Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer InstituteM C Christian, J M Pluda, P T Ho, et al.
Pageof 6